↓ Skip to main content

Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis…

Overview of attention for article published in Rheumatology, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
6 X users
patent
1 patent

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
Published in
Rheumatology, January 2013
DOI 10.1093/rheumatology/kes413
Pubmed ID
Authors

Sanne A. A. van Dartel, Jaap Fransen, Wietske Kievit, Ellen A. J. Dutmer, Herman L. M. Brus, Nella M. Houtman, Mart A. F. van de Laar, Piet L. C. M. van Riel

Abstract

The use of TNF inhibitors leads to an increased risk of serious infections in RA. Predicting this risk would facilitate the prevention of serious infections. The objective of this study was to identify which factors are predictive of the increased risk of serious infections in RA patients treated with TNF inhibiting therapy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 2%
United Kingdom 1 2%
Argentina 1 2%
Brazil 1 2%
Unknown 56 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 18%
Other 8 13%
Student > Ph. D. Student 7 12%
Student > Master 6 10%
Student > Postgraduate 5 8%
Other 17 28%
Unknown 6 10%
Readers by discipline Count As %
Medicine and Dentistry 30 50%
Psychology 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Agricultural and Biological Sciences 3 5%
Immunology and Microbiology 2 3%
Other 7 12%
Unknown 9 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2017.
All research outputs
#4,451,763
of 22,694,633 outputs
Outputs from Rheumatology
#1,811
of 6,201 outputs
Outputs of similar age
#48,927
of 282,145 outputs
Outputs of similar age from Rheumatology
#15
of 66 outputs
Altmetric has tracked 22,694,633 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,201 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,145 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.